Forward Equity Partners

Forward Equity Partners is a private equity firm specializing in healthcare and life sciences investments across South Korea and the United States. The firm focuses on innovative companies that provide essential technology and infrastructure for human health advancement. Their portfolio includes investments in biotechnology, pharmaceuticals, and therapeutics sectors.

The firm's investment strategy emphasizes cross-border transactions, leveraging its expertise in both the U.S. and South Korean markets. They target growth-stage companies with high potential, aiming to build successful partnerships with company management teams. Forward Equity Partners has a proven track record in cross-border healthcare transactions, having led multiple investments in the sector.

The team comprises industry veterans with extensive experience in healthcare investment and biotech corporate roles. Notable team members include CEO and Managing Director Paul H. Kim, who has over 30 years of experience in healthcare investment and biotech corporate executive roles, and Managing Partner Hong Jun Park, who has managed diverse mezzanine investment funds and high-interest accompanying bonds. Their combined expertise enables the firm to identify and support companies poised for significant growth in the healthcare and life sciences industries.